Jorge Daza

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Venues

BJU international

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge Daza, Bérengère Salomé, Kennedy E Okhawere, Octavia Bane, Kirolos N Meilika, Talia G Korn, Jingjing Qi, Hui Xe, Manishkumar Patel, Rachel Brody, Seunghee Kim-Schultz, John P Sfakianos, Sara Lewis, Jordan M Rich, Laura Zuluaga, Ketan K Badani, Amir Horowitz
Urine supernatant reveals a signature that predicts survival in clear cell renal cell carcinoma. BJU international (2023)
Jorge Daza, Bérengère Salomé, Kennedy E Okhawere, Octavia Bane, Kirolos N Meilika, Talia G Korn, Jingjing Qi, Hui Xe, Manishkumar Patel, Rachel Brody, Seunghee Kim-Schulze, John P Sfakianos, Sara Lewis, Jordan M Rich, Laura Zuluaga, Ketan K Badani, Amir Horowitz
Urine supernatant reveals a signature that predicts survival in clear-cell renal cell carcinoma. BJU international (2023)
Jorge Daza, Bérengère Salomé, Kennedy E Okhawere, Octavia Bane, Kirolos N Meilika, Talia G Korn, Jingjing Qi, Hui Xe, Manishkumar Patel, Rachel Brody, Seunghee Kim-Schultz, John P Sfakianos, Sara Lewis, Jordan M Rich, Laura Zuluaga, Ketan K Badani, Amir Horowitz
Urine supernatant reveals a signature that predicts survival in clear-cell renal cell carcinoma. BJU international (2023)
Haocheng Yu, John P Sfakianos, Li Wang, Yang Hu, Jorge Daza, Matthew D Galsky, Harkirat S Sandhu, Olivier Elemento, Bishoy Morris Faltas, Adam M Farkas, Nina Bhardwaj, Jun Zhu, David J Mulholland
Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfβ-Dependent Mechanisms. Molecular cancer therapeutics 21 (11) (2022)

Jorge Daza.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jorge Daza